According to Adial Pharmaceuticals
's latest financial reports the company has $0.31 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $4 M | -33.99% |
2021-12-31 | $6.06 M | 37.74% |
2020-12-31 | $4.4 M | -35.06% |
2019-12-31 | $6.77 M | 75.16% |
2018-12-31 | $3.86 M | 21102.56% |
2017-12-31 | $0.01 M | -79.26% |
2016-12-31 | $0.08 M | -45.81% |
2015-12-31 | $0.16 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.13 M | -58.21% | Bahamas |
NRC Health
NRC | $6.65 M | 2,006.18% | ๐บ๐ธ USA |